FundedIQ
Biotechnology

CubaseBio: Funding, Investors & Team (Sep 2026)

Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.

www.cubasebio.com LinkedIn Stockholm, Sweden 1-10 employees
Biotechnology Medical B2B
Total raised
$4.6M
Rounds
1
Latest
Seed
Feb 2026

CubaseBio has raised $4.6M across 1 funding round on record, the most recent a Seed of $4.6M announced in Feb 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

CubaseBio Company Profile and Key Stats

Total funding raised
$4.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$4.6M in Feb 2026
Employees
1-10
reported band
Headquarters
Stockholm, Sweden

Latest funding round on record: Feb 2026.

CubaseBio Funding Rounds

Date
Round
Amount
Seed
$4.6M

CubaseBio Founders and Leadership Team

Name
Role
Contact
Toon Verheyen
Founder

No contact details are on record for this team yet.

CubaseBio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
688
$4.2M
16,485
$3.1M

CubaseBio's latest round of $4.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like CubaseBio in Biotechnology and Stockholm

Companies Similar to CubaseBio

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…

Series B $15.5M

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…

Undisclosed round $1.4M

Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.

Pre-Seed $740k

Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…

Undisclosed round $790k

OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…

Undisclosed round $1.6M

Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…

Undisclosed round $150k

Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…

Undisclosed round $2.1M

Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…

Undisclosed round $20.0M

Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…

Undisclosed round $60k

Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…

Undisclosed round $11.9M

Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…

Undisclosed round $9.3M

ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…

Undisclosed round $7.4M

CubaseBio Funding FAQs

What does CubaseBio do?

Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.

How much funding has CubaseBio raised?

CubaseBio has raised $4.6M across 1 round on record. The most recent is a Seed of $4.6M announced in Feb 2026.

When did CubaseBio last raise funding?

CubaseBio's most recent funding round on record is a Seed of $4.6M, announced in Feb 2026.

Who founded CubaseBio?

FundedIQ lists Toon Verheyen (Founder) at CubaseBio.

Where is CubaseBio headquartered?

CubaseBio is based in Stockholm, Stockholms Lan, Sweden.

How many employees does CubaseBio have?

CubaseBio is in the 1-10 employee band.

How does CubaseBio's funding compare to other Biotechnology startups?

CubaseBio's latest round of $4.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's CubaseBio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CubaseBio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.